Vitamin D and K signaling pathways in hepatocellular carcinoma

Publication date: 20 September 2017
Source:Gene, Volume 629
Author(s): Manal L. Louka, Ahmed M. Fawzy, Abdelrahman M. Naiem, Mustafa F. Elseknedy, Ahmed E. Abdelhalim, Mohamed A. Abdelghany
Hepatocellular carcinoma (HCC) is a primary liver malignancy, and is now the six most common in between malignancies. Early diagnosis of HCC with prompt treatment increases the opportunity of patients to survive. With the advances in understanding the molecular biology of HCC, new therapeutic strategies to treat HCC have emerged. There is a growing consensus that vitamins are important for the control of various cancers. Biochemical evidence clearly indicates that HCC cells are responsive to the inhibitory effect of vitamin D, vitamin D analogues and vitamin K. In this review, we summarize the mechanisms used by vitamin D and K to influence the development of HCC and the latest development of vitamin analogues for potential HCC therapy.



from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2vCjbrw
via IFTTT